RE:RE:ONCY Goblet-1 trial pancreatic trial -> COMPLETE RESPONSE !The preclinical biopharma company Trillium Therapeutics without a proven technology was acquired by Pfizer for US$2.4 Billion while Biohaven Pharmaceuticals, a platform technology company like ONCY's platform technology pelareorep, was also acquired by Pfizer for US$11.6 Billion. These examples strongly suggest that ONCY's platform technology pelareorep is worth significantly north of >US$8 Billion in a M&A deal.